Terri Lee

Terri Lee currently works in the Business Development and Corporate Strategy group at BioMarin Pharmaceutical, a role she assumed in January 2024 after spending approximately five years as the Head of Corporate Development and Strategy at MPM Stealth NewCo. Her extensive professional background includes completing a specialized fellowship on the investment team at MPM Capital and serving as an Operations Manager at Aeton Therapeutics. Before transitioning into her current corporate strategy trajectory, she held early scientific research and business development positions at the Gladstone Institutes and UCSF. She holds a PhD in Biochemistry and Molecular Biology from UCSF, alongside a Bachelor of Science in Microbiology and Pharmacology from UC Santa Barbara. Lee's professional expertise centers on bridging scientific research with corporate development, business development, and venture investment across the life sciences and biotechnology sectors.